These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37933122)

  • 1. Optimizing statin therapy for primary prevention of cardiovascular disease in type 2 diabetes mellitus patients
    Yu JM; Chen WM; Shia BC; Wu SY
    Diab Vasc Dis Res; 2023; 20(6):14791641231214507. PubMed ID: 37933122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes of statin dose, class, and use intensity on primary prevention of cardiovascular mortality: a national T2DM cohort study.
    Yu JM; Chen WM; Shia BC; Wu SY
    Eur J Clin Pharmacol; 2023 May; 79(5):687-700. PubMed ID: 37010535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective Effects of Different Classes, Intensity, Cumulative Dose-Dependent of Statins Against Primary Ischemic Stroke in Patients with Type 2 Diabetes Mellitus.
    Yu JM; Chen WM; Shia BC; Wu SY
    Curr Atheroscler Rep; 2023 Sep; 25(9):619-628. PubMed ID: 37515725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin therapy on glycemic control in type 2 diabetic patients: A network meta-analysis.
    Cui JY; Zhou RR; Han S; Wang TS; Wang LQ; Xie XH
    J Clin Pharm Ther; 2018 Aug; 43(4):556-570. PubMed ID: 29733433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescribing pattern of statins for primary prevention of cardiovascular diseases in patients with type 2 diabetes: insights from Ethiopia.
    Demoz GT; Wahdey S; Kasahun GG; Hagazy K; Kinfe DG; Tasew H; Bahrey D; Niriayo YL
    BMC Res Notes; 2019 Jul; 12(1):386. PubMed ID: 31288848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of incident diabetes among patients treated with statins: population based study.
    Carter AA; Gomes T; Camacho X; Juurlink DN; Shah BR; Mamdani MM
    BMJ; 2013 May; 346():f2610. PubMed ID: 23704171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal statin use for prevention of sepsis in type 2 diabetes mellitus.
    Sun M; Tao Y; Chen WM; Wu SY; Zhang J
    Diabetol Metab Syndr; 2023 Apr; 15(1):75. PubMed ID: 37072863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effectiveness and safety of statins as a class and of specific statins for primary prevention of cardiovascular disease: A systematic review, meta-analysis, and network meta-analysis of randomized trials with 94,283 participants.
    Yebyo HG; Aschmann HE; Kaufmann M; Puhan MA
    Am Heart J; 2019 Apr; 210():18-28. PubMed ID: 30716508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Finding the Balance Between Benefits and Harms When Using Statins for Primary Prevention of Cardiovascular Disease: A Modeling Study.
    Yebyo HG; Aschmann HE; Puhan MA
    Ann Intern Med; 2019 Jan; 170(1):1-10. PubMed ID: 30508425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of statins for primary prevention of cardiovascular disease and persistent physical disability in older adults.
    Zhou Z; Curtis AJ; Ernst ME; Ryan J; Zoungas S; Wolfe R; McNeil JJ; Murray AM; Reid CM; Chowdhury EK; Woods RL; Tonkin AM; Nelson MR
    Eur J Clin Pharmacol; 2022 Mar; 78(3):467-476. PubMed ID: 34698889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin Treatment and Clinical Outcomes of Heart Failure Among Africans: An Inverse Probability Treatment Weighted Analysis.
    Bonsu KO; Owusu IK; Buabeng KO; Reidpath DD; Kadirvelu A
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28365564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin therapy and related risk of new-onset type 2 diabetes mellitus.
    Ruscica M; Macchi C; Morlotti B; Sirtori CR; Magni P
    Eur J Intern Med; 2014 Jun; 25(5):401-6. PubMed ID: 24685426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effectiveness of statins in secondary prevention among the older people aged 75 years and over.
    Kwak A; Kim JH; Choi CU; Kim IW; Oh JM; Kim K
    Int J Clin Pharm; 2019 Apr; 41(2):460-469. PubMed ID: 30864086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A survey of the FDA's AERS database regarding muscle and tendon adverse events linked to the statin drug class.
    Hoffman KB; Kraus C; Dimbil M; Golomb BA
    PLoS One; 2012; 7(8):e42866. PubMed ID: 22936996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular disease preventive effects of aspirin combined with different statins in the United States general population.
    Liu T; Zuo R; Wang J; Huangtao Z; Wang B; Sun L; Wang S; Li B; Zhu Z; Pan Y
    Sci Rep; 2023 Mar; 13(1):4585. PubMed ID: 36941404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Pitavastatin Compared with Atorvastatin andRosuvastatin on New-Onset Diabetes Mellitus in PatientsWith Acute Myocardial Infarction.
    Choi JY; Choi CU; Hwang SY; Choi BG; Jang WY; Kim DY; Kim W; Park EJ; Lee S; Na JO; Kim JW; Kim EJ; Rha SW; Park CG; Seo HS; Chae SC; Kim YJ; Cho MC; Kim CJ; Kim HS; Jeong MH;
    Am J Cardiol; 2018 Sep; 122(6):922-928. PubMed ID: 30217375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review and economic evaluation of statins for the prevention of coronary events.
    Ward S; Lloyd Jones M; Pandor A; Holmes M; Ara R; Ryan A; Yeo W; Payne N
    Health Technol Assess; 2007 Apr; 11(14):1-160, iii-iv. PubMed ID: 17408535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective Effects Against Dementia Undergo Different Statin Type, Intensity, and Cumulative Dose in Older Adult Type 2 Diabetes Mellitus Patients.
    Sun M; Chen WM; Wu SY; Zhang J
    J Am Med Dir Assoc; 2024 Mar; 25(3):470-479.e1. PubMed ID: 38128583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 10-year trends in statin utilization in Taiwan: a retrospective study using Taiwan's National Health Insurance Research Database.
    Hsieh HC; Hsu JC; Lu CY
    BMJ Open; 2017 May; 7(5):e014150. PubMed ID: 28515189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of statins on the incidence of NAFLD-related decompensated cirrhosis in T2DM.
    Wu SY; Chen WM; Chiang MF; Lo HC; Wu MS; Lee MC; Soong RS
    Liver Int; 2023 Oct; 43(10):2232-2244. PubMed ID: 37381761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.